Buloxibutid not checked
Vicore Pharma AB · C21 · Compund 21
FollowEvery change as it happens, and a Monday email
Trials
1 active
7 in total · 1 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Idiopathic Pulmonary Fibrosis (IPF)
- Main trialPhase 2
- “The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and pharmacokinetics of orally administered buloxibutid, either on top of stable IPF therapy or as monotherapy, are assessed in participants with IPF. Trial website: www.aspire-ipf.com”In the company’s words, NCT06588686 on ClinicalTrials.gov
- Other names
- C21 · Compund 21 · Compound 21
Other drugs for Idiopathic Pulmonary Fibrosis (IPF)
- SC1011JOYO Pharma · Phase 2/3
- NerandomilastBoehringer Ingelheim · Phase 3
- NAL ERTrevi Therapeutics · Phase 3
- AK3280Shanghai Ark Biopharmaceutical Co., Ltd. · Phase 3
- TDI01Beijing Tide Pharmaceutical Co., Ltd · Phase 3
- INS018_055InSilico Medicine Hong Kong Limited · Phase 3
Coming up1
- May 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Active, not recruiting | May 2027 | A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. | |
| Phase 3Completed | 25 Apr 2022 | A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects | |
| Phase 2Completed | 13 Oct 2020 | Safety and Efficacy of C21 in Subjects With COVID-19 | |
| Phase 2Completed | 14 Dec 2020 | Cold Challenge With C21 in RP | |
| Phase 2Completed | 30 Mar 2024 | Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF | |
| Phase 1Completed | 11 May 2022 | Effect of C21 on Forearm Blood Flow | |
| Phase 1Completed | 16 Jun 2023 | A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026